{
    "nctId": "NCT01621659",
    "briefTitle": "Multidisciplinary Team IntervenTion in CArdio-ONcology (TITAN Study)",
    "officialTitle": "Multidisciplinary Team IntervenTion in CArdio-ONcology",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 80,
    "primaryOutcomeMeasure": "cardiac MRI",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* histologically confirmed malignancy (breast or lymphoma);\n* scheduled to receive anthracycline and/or trastuzumab-based chemotherapy;\n* age \u2265 18 years;\n* willing to attend follow-up visits.\n\nExclusion Criteria:\n\n* physical disability preventing exercise testing or DEXA scan;\n* psychiatric disease or disorder precluding informed consent;\n* participation in other cardiotoxicity or exercise intervention study;\n* contraindication to anti-cancer therapy, including known heart failure, cardiomyopathy, or baseline LVEF \\< 50%;\n* previous anthracycline or trastuzumab-based therapy;\n* previous radiotherapy to thorax.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}